Skip to content
X FACTOR PEPTIDES

FOR IMMEDIATE RELEASE · JUNE 4, 2026

X Factor Peptides launches with a per-lot HPLC transparency standard for the research-peptide supply chain

Every vial ships with its actual chromatogram. Every lot is publicly searchable by number. Researchers no longer have to trust a generic spec sheet.

BALTIMORE, MD — June 4, 2026 —

X Factor Peptides, a US-based supplier of research-grade peptide reference standards, today launched with what may be the most aggressive transparency policy in the Research Use Only (RUO) peptide supply space: a per-lot HPLC purity certificate ships inside every vial, and the same certificate is publicly searchable at xfactorpeptidelab.com/coa by lot number — no customer login required.

The launch targets a documented credibility gap in the research-peptide market. A 2024 review found that under 30% of RUO peptide suppliers publish per-lot analytical data; most ship a generic spec sheet that describes what the molecule is supposed to be, not what the specific vial in the researcher's hand actually contains. The mismatch contributes to irreproducibility in preclinical pharmacology and drives independent re-validation costs that often exceed the price of the material itself.

"You can buy a peptide for $40 and pay your analytical lab $400 to confirm it. We thought that was backwards. So we built the company around the assumption that the buyer should never have to repeat our work."
— Alexander Mills, Founder

What ships with every order

Retention guarantee

A reserve aliquot of every released lot stays at −80°C for 24 months. If a customer challenges a result, the supplier can pull the reserve and re-run the analytical HPLC against the customer's sample at no charge.

RUO compliance posture

X Factor Peptides ships only for Research Use Only. Each order requires age-21+, RUO-use, and Terms-of-Service attestation. The company does not provide dosing recommendations, does not market peptides for cosmetic, performance, or therapeutic use, and operates under a publicly posted California Proposition 65 disclosure and AML/KYC policy. Full legal hub at /legal.

Product catalog at launch

Thirteen catalog SKUs at launch: BPC-157, TB-500, GHK-Cu, CJC-1295, Ipamorelin, Sermorelin, Tesamorelin, Semaglutide, Epitalon, MOTS-c, Retatrutide (GLP-3R), and the GLOW + KLOW research stacks. Custom synthesis available for institutional buyers at /custom-synthesis (10 mg pilot through 5 g scale-up, NDA on request, 3–6 week turnaround).

For wholesale and institutional buyers

Net-30 terms, white-label COAs, and bulk pricing available for verified academic, biotech, and clinical research buyers. Institutional inquiry form at /wholesale.

About X Factor Peptides

X Factor Peptides is a US-based supplier of research-grade peptide reference standards for laboratory and pre-clinical research use. Operations in Maryland, USA. We are not a pharmacy, not a compounder, and not a telehealth provider. Founded 2026.

Press contact

Press: press@xfactorpeptidelab.com

Wholesale: wholesale@xfactorpeptidelab.com

Security disclosure: security@xfactorpeptidelab.com

Press kit assets, logos, and founder bio at /press.


### END ###

Editorial note: X Factor Peptides products are research reagents, not pharmaceuticals. The company does not provide dosing, therapeutic, or diagnostic guidance.